APO Research
Talk to an analyst

APO RESEARCH · REPORT

Botanical and Plant Derived Drugs

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Botanical and Plant Derived Drugs Market Outlook and Growth Opportunities 2026

22 December 2025190 pages

Choose your research edition.

Industry ResearchBotanical and Plant Derived Drugs Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Botanical and Plant Derived Drugs Industry Growth and Trends Forecast to 203289 pages · $3,450 USDMarket StructureGlobal Botanical and Plant Derived Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Botanical and Plant Derived Drugs Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Botanical and Plant Derived Drugs Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Botanical and Plant Derived Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Botanical and Plant Derived Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Botanical and Plant Derived Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Botanical and Plant Derived Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Botanical and Plant Derived Drugs market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Botanical and Plant Derived Drugs market include Abott Laboratories, Bayer Healthcare, Bristol Myers, Curapharm and Bionova, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Botanical and Plant Derived Drugs market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Botanical and Plant Derived Drugs and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Botanical and Plant Derived Drugs revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Botanical and Plant Derived Drugs market.

Botanical and Plant Derived Drugs Segment by Company

Abott Laboratories

Bayer Healthcare

Bristol Myers

Curapharm

Bionova

Botanical and Plant Derived Drugs Segment by Type

Injections

Pills

Tablets

Capsules

Botanical and Plant Derived Drugs Segment by Application

Hospital Pharmacies

Drug Stores

Online Pharmacies

Retail Pharmacies

Botanical and Plant Derived Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Botanical and Plant Derived Drugs status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Botanical and Plant Derived Drugs key companies, revenue, market share, and recent developments.

3. To split the Botanical and Plant Derived Drugs breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Botanical and Plant Derived Drugs market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Botanical and Plant Derived Drugs significant trends, drivers, influence factors in global and regions.

6. To analyze Botanical and Plant Derived Drugs competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Botanical and Plant Derived Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Botanical and Plant Derived Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Botanical and Plant Derived Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Botanical and Plant Derived Drugs industry.

Chapter 3: Detailed analysis of Botanical and Plant Derived Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Botanical and Plant Derived Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Botanical and Plant Derived Drugs in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Botanical and Plant Derived Drugs Industry Trends Table 2. Botanical and Plant Derived Drugs Industry Drivers Table 3. Botanical and Plant Derived Drugs Industry Opportunities and Challenges Table 4. Botanical and Plant Derived Drugs Industry Restraints Table 5. Global Botanical and Plant Derived Drugs Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Botanical and Plant Derived Drugs Revenue Share by Company (2021-2026) Table 7. Global Botanical and Plant Derived Drugs Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Botanical and Plant Derived Drugs Key Company Manufacturing Base & Headquarters Table 9. Global Botanical and Plant Derived Drugs Company, Product Type & Application Table 10. Global Botanical and Plant Derived Drugs Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Botanical and Plant Derived Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Injections Table 15. Significant Companies of Pills Table 16. Significant Companies of Tablets Table 17. Significant Companies of Capsules Table 18. Global Botanical and Plant Derived Drugs Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Botanical and Plant Derived Drugs Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global Botanical and Plant Derived Drugs Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global Botanical and Plant Derived Drugs Sales Value Share by Type (2021-2026) Table 22. Global Botanical and Plant Derived Drugs Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Hospital Pharmacies Table 24. Significant Companies of Drug Stores Table 25. Significant Companies of Online Pharmacies Table 26. Significant Companies of Retail Pharmacies Table 27. Global Botanical and Plant Derived Drugs Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Botanical and Plant Derived Drugs Sales Value by Application (2021-2026) & (US$ Million) Table 29. Global Botanical and Plant Derived Drugs Sales Value by Application (2027-2032) & (US$ Million) Table 30. Global Botanical and Plant Derived Drugs Sales Value Share by Application (2021-2026) Table 31. Global Botanical and Plant Derived Drugs Sales Value Share by Application (2027-2032) Table 32. Global Botanical and Plant Derived Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Botanical and Plant Derived Drugs Sales Value by Region (2021-2026) & (US$ Million) Table 34. Global Botanical and Plant Derived Drugs Sales Value Share by Region (2021-2026) Table 35. Global Botanical and Plant Derived Drugs Sales Value by Region (2027-2032) & (US$ Million) Table 36. Global Botanical and Plant Derived Drugs Sales Value Share by Region (2027-2032) Table 37. Global Botanical and Plant Derived Drugs Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Botanical and Plant Derived Drugs Sales Value by Country (2021-2026) & (US$ Million) Table 39. Global Botanical and Plant Derived Drugs Sales Value Market Share by Country (2021-2026) Table 40. Global Botanical and Plant Derived Drugs Sales Value by Country (2027-2032) & (US$ Million) Table 41. Global Botanical and Plant Derived Drugs Sales Value Market Share by Country (2027-2032) Table 42. Abott Laboratories Company Information Table 43. Abott Laboratories Business Overview Table 44. Abott Laboratories Botanical and Plant Derived Drugs Revenue (US$ Million) and Gross Margin (2021-2026) Table 45. Abott Laboratories Botanical and Plant Derived Drugs Product Portfolio Table 46. Abott Laboratories Recent Development Table 47. Bayer Healthcare Company Information Table 48. Bayer Healthcare Business Overview Table 49. Bayer Healthcare Botanical and Plant Derived Drugs Revenue (US$ Million) and Gross Margin (2021-2026) Table 50. Bayer Healthcare Botanical and Plant Derived Drugs Product Portfolio Table 51. Bayer Healthcare Recent Development Table 52. Bristol Myers Company Information Table 53. Bristol Myers Business Overview Table 54. Bristol Myers Botanical and Plant Derived Drugs Revenue (US$ Million) and Gross Margin (2021-2026) Table 55. Bristol Myers Botanical and Plant Derived Drugs Product Portfolio Table 56. Bristol Myers Recent Development Table 57. Curapharm Company Information Table 58. Curapharm Business Overview Table 59. Curapharm Botanical and Plant Derived Drugs Revenue (US$ Million) and Gross Margin (2021-2026) Table 60. Curapharm Botanical and Plant Derived Drugs Product Portfolio Table 61. Curapharm Recent Development Table 62. Bionova Company Information Table 63. Bionova Business Overview Table 64. Bionova Botanical and Plant Derived Drugs Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Bionova Botanical and Plant Derived Drugs Product Portfolio Table 66. Bionova Recent Development Table 67. Research Programs/Design for This Report Table 68. Authors List of This Report Table 69. Secondary Sources Table 70. Primary Sources List of Figures Figure 1. Botanical and Plant Derived Drugs Product Image Figure 2. Global Botanical and Plant Derived Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Botanical and Plant Derived Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Botanical and Plant Derived Drugs Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Injections Image Figure 8. Pills Image Figure 9. Tablets Image Figure 10. Capsules Image Figure 11. Global Botanical and Plant Derived Drugs Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Botanical and Plant Derived Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global Botanical and Plant Derived Drugs Sales Value Share by Type (2021-2032) Figure 14. Hospital Pharmacies Image Figure 15. Drug Stores Image Figure 16. Online Pharmacies Image Figure 17. Retail Pharmacies Image Figure 18. Global Botanical and Plant Derived Drugs Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Botanical and Plant Derived Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global Botanical and Plant Derived Drugs Sales Value Share by Application (2021-2032) Figure 21. Global Botanical and Plant Derived Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 22. Global Botanical and Plant Derived Drugs Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 23. North America Botanical and Plant Derived Drugs Sales Value (2021-2032) & (US$ Million) Figure 24. North America Botanical and Plant Derived Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Europe Botanical and Plant Derived Drugs Sales Value (2021-2032) & (US$ Million) Figure 26. Europe Botanical and Plant Derived Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Asia-Pacific Botanical and Plant Derived Drugs Sales Value (2021-2032) & (US$ Million) Figure 28. Asia-Pacific Botanical and Plant Derived Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 29. South America Botanical and Plant Derived Drugs Sales Value (2021-2032) & (US$ Million) Figure 30. South America Botanical and Plant Derived Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Middle East & Africa Botanical and Plant Derived Drugs Sales Value (2021-2032) & (US$ Million) Figure 32. Middle East & Africa Botanical and Plant Derived Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 33. USA Botanical and Plant Derived Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. USA Botanical and Plant Derived Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. USA Botanical and Plant Derived Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Canada Botanical and Plant Derived Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Canada Botanical and Plant Derived Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Canada Botanical and Plant Derived Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Mexico Botanical and Plant Derived Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Mexico Botanical and Plant Derived Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Mexico Botanical and Plant Derived Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Germany Botanical and Plant Derived Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Germany Botanical and Plant Derived Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Germany Botanical and Plant Derived Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. France Botanical and Plant Derived Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. France Botanical and Plant Derived Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. France Botanical and Plant Derived Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. U.K. Botanical and Plant Derived Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. U.K. Botanical and Plant Derived Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. U.K. Botanical and Plant Derived Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Italy Botanical and Plant Derived Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Italy Botanical and Plant Derived Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Italy Botanical and Plant Derived Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Spain Botanical and Plant Derived Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Spain Botanical and Plant Derived Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Spain Botanical and Plant Derived Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Russia Botanical and Plant Derived Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Russia Botanical and Plant Derived Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Russia Botanical and Plant Derived Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Netherlands Botanical and Plant Derived Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Netherlands Botanical and Plant Derived Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Netherlands Botanical and Plant Derived Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Nordic Countries Botanical and Plant Derived Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Nordic Countries Botanical and Plant Derived Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Nordic Countries Botanical and Plant Derived Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. China Botanical and Plant Derived Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. China Botanical and Plant Derived Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. China Botanical and Plant Derived Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Japan Botanical and Plant Derived Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Japan Botanical and Plant Derived Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Japan Botanical and Plant Derived Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. South Korea Botanical and Plant Derived Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. South Korea Botanical and Plant Derived Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. South Korea Botanical and Plant Derived Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. India Botanical and Plant Derived Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. India Botanical and Plant Derived Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. India Botanical and Plant Derived Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Australia Botanical and Plant Derived Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Australia Botanical and Plant Derived Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Australia Botanical and Plant Derived Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Southeast Asia Botanical and Plant Derived Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Southeast Asia Botanical and Plant Derived Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Southeast Asia Botanical and Plant Derived Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Brazil Botanical and Plant Derived Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Brazil Botanical and Plant Derived Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Brazil Botanical and Plant Derived Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Argentina Botanical and Plant Derived Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Argentina Botanical and Plant Derived Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Argentina Botanical and Plant Derived Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Chile Botanical and Plant Derived Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Chile Botanical and Plant Derived Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Chile Botanical and Plant Derived Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Colombia Botanical and Plant Derived Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Colombia Botanical and Plant Derived Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Colombia Botanical and Plant Derived Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Peru Botanical and Plant Derived Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Peru Botanical and Plant Derived Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Peru Botanical and Plant Derived Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Botanical and Plant Derived Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Saudi Arabia Botanical and Plant Derived Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Saudi Arabia Botanical and Plant Derived Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Israel Botanical and Plant Derived Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Israel Botanical and Plant Derived Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Israel Botanical and Plant Derived Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. UAE Botanical and Plant Derived Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. UAE Botanical and Plant Derived Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. UAE Botanical and Plant Derived Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Turkey Botanical and Plant Derived Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Turkey Botanical and Plant Derived Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Turkey Botanical and Plant Derived Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Iran Botanical and Plant Derived Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Iran Botanical and Plant Derived Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Iran Botanical and Plant Derived Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Egypt Botanical and Plant Derived Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Egypt Botanical and Plant Derived Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Egypt Botanical and Plant Derived Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Years Considered Figure 118. Research Process Figure 119. Key Executives Interviewed

Scope & coverage.

Types
  • Injections
  • Pills
  • Tablets
  • Capsules
Applications
  • Hospital Pharmacies
  • Drug Stores
  • Online Pharmacies
  • Retail Pharmacies
Companies covered
  • Abott Laboratories
  • Bayer Healthcare
  • Bristol Myers
  • Curapharm
  • Bionova

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Botanical and Plant Derived Drugs Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Botanical and Plant Derived Drugs Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Botanical and Plant Derived Drugs Market Dynamics
  1. 2.1 Botanical and Plant Derived Drugs Industry Trends
  2. 2.2 Botanical and Plant Derived Drugs Industry Drivers
  3. 2.3 Botanical and Plant Derived Drugs Industry Opportunities and Challenges
  4. 2.4 Botanical and Plant Derived Drugs Industry Restraints
3 Botanical and Plant Derived Drugs Market by Company
  1. 3.1 Global Botanical and Plant Derived Drugs Company Revenue Ranking in 2025
  2. 3.2 Global Botanical and Plant Derived Drugs Revenue by Company (2021-2026)
  3. 3.3 Global Botanical and Plant Derived Drugs Company Ranking (2024-2026)
  4. 3.4 Global Botanical and Plant Derived Drugs Company Manufacturing Base and Headquarters
  5. 3.5 Global Botanical and Plant Derived Drugs Company Product Type and Application
  6. 3.6 Global Botanical and Plant Derived Drugs Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Botanical and Plant Derived Drugs Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Botanical and Plant Derived Drugs Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Botanical and Plant Derived Drugs Market by Type
  1. 4.1 Botanical and Plant Derived Drugs Type Introduction
  2. 4.1.1 Injections
  3. 4.1.2 Pills
  4. 4.1.3 Tablets
  5. 4.1.4 Capsules
  6. 4.2 Global Botanical and Plant Derived Drugs Sales Value by Type
  7. 4.2.1 Global Botanical and Plant Derived Drugs Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Botanical and Plant Derived Drugs Sales Value by Type (2021-2032)
  9. 4.2.3 Global Botanical and Plant Derived Drugs Sales Value Share by Type (2021-2032)
5 Botanical and Plant Derived Drugs Market by Application
  1. 5.1 Botanical and Plant Derived Drugs Application Introduction
  2. 5.1.1 Hospital Pharmacies
  3. 5.1.2 Drug Stores
  4. 5.1.3 Online Pharmacies
  5. 5.1.4 Retail Pharmacies
  6. 5.2 Global Botanical and Plant Derived Drugs Sales Value by Application
  7. 5.2.1 Global Botanical and Plant Derived Drugs Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Botanical and Plant Derived Drugs Sales Value by Application (2021-2032)
  9. 5.2.3 Global Botanical and Plant Derived Drugs Sales Value Share by Application (2021-2032)
6 Botanical and Plant Derived Drugs Regional Value Analysis
  1. 6.1 Global Botanical and Plant Derived Drugs Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Botanical and Plant Derived Drugs Sales Value by Region (2021-2032)
  3. 6.2.1 Global Botanical and Plant Derived Drugs Sales Value by Region: 2021-2026
  4. 6.2.2 Global Botanical and Plant Derived Drugs Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Botanical and Plant Derived Drugs Sales Value (2021-2032)
  7. 6.3.2 North America Botanical and Plant Derived Drugs Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Botanical and Plant Derived Drugs Sales Value (2021-2032)
  10. 6.4.2 Europe Botanical and Plant Derived Drugs Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Botanical and Plant Derived Drugs Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Botanical and Plant Derived Drugs Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Botanical and Plant Derived Drugs Sales Value (2021-2032)
  16. 6.6.2 South America Botanical and Plant Derived Drugs Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Botanical and Plant Derived Drugs Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Botanical and Plant Derived Drugs Sales Value Share by Country, 2025 VS 2032
7 Botanical and Plant Derived Drugs Country-level Value Analysis
  1. 7.1 Global Botanical and Plant Derived Drugs Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Botanical and Plant Derived Drugs Sales Value by Country (2021-2032)
  3. 7.2.1 Global Botanical and Plant Derived Drugs Sales Value by Country (2021-2026)
  4. 7.2.2 Global Botanical and Plant Derived Drugs Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Botanical and Plant Derived Drugs Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Botanical and Plant Derived Drugs Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Botanical and Plant Derived Drugs Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Botanical and Plant Derived Drugs Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Botanical and Plant Derived Drugs Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Botanical and Plant Derived Drugs Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Botanical and Plant Derived Drugs Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Botanical and Plant Derived Drugs Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Botanical and Plant Derived Drugs Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Botanical and Plant Derived Drugs Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Botanical and Plant Derived Drugs Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Botanical and Plant Derived Drugs Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Botanical and Plant Derived Drugs Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Botanical and Plant Derived Drugs Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Botanical and Plant Derived Drugs Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Botanical and Plant Derived Drugs Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Botanical and Plant Derived Drugs Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Botanical and Plant Derived Drugs Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Botanical and Plant Derived Drugs Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Botanical and Plant Derived Drugs Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Botanical and Plant Derived Drugs Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Botanical and Plant Derived Drugs Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Botanical and Plant Derived Drugs Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Botanical and Plant Derived Drugs Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Botanical and Plant Derived Drugs Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Botanical and Plant Derived Drugs Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Botanical and Plant Derived Drugs Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Botanical and Plant Derived Drugs Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Botanical and Plant Derived Drugs Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Botanical and Plant Derived Drugs Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Botanical and Plant Derived Drugs Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Botanical and Plant Derived Drugs Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Botanical and Plant Derived Drugs Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Botanical and Plant Derived Drugs Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Botanical and Plant Derived Drugs Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Botanical and Plant Derived Drugs Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Botanical and Plant Derived Drugs Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Botanical and Plant Derived Drugs Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Botanical and Plant Derived Drugs Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Botanical and Plant Derived Drugs Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Botanical and Plant Derived Drugs Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Botanical and Plant Derived Drugs Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Botanical and Plant Derived Drugs Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Botanical and Plant Derived Drugs Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Botanical and Plant Derived Drugs Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Botanical and Plant Derived Drugs Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Botanical and Plant Derived Drugs Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Botanical and Plant Derived Drugs Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Botanical and Plant Derived Drugs Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Botanical and Plant Derived Drugs Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Botanical and Plant Derived Drugs Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Botanical and Plant Derived Drugs Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Botanical and Plant Derived Drugs Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Botanical and Plant Derived Drugs Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Botanical and Plant Derived Drugs Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Botanical and Plant Derived Drugs Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Botanical and Plant Derived Drugs Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Botanical and Plant Derived Drugs Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Botanical and Plant Derived Drugs Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Botanical and Plant Derived Drugs Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Botanical and Plant Derived Drugs Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Botanical and Plant Derived Drugs Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Botanical and Plant Derived Drugs Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Botanical and Plant Derived Drugs Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Botanical and Plant Derived Drugs Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Botanical and Plant Derived Drugs Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Botanical and Plant Derived Drugs Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Botanical and Plant Derived Drugs Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Botanical and Plant Derived Drugs Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Botanical and Plant Derived Drugs Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Botanical and Plant Derived Drugs Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Botanical and Plant Derived Drugs Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Botanical and Plant Derived Drugs Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Botanical and Plant Derived Drugs Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Botanical and Plant Derived Drugs Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Botanical and Plant Derived Drugs Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Botanical and Plant Derived Drugs Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Botanical and Plant Derived Drugs Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Botanical and Plant Derived Drugs Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Botanical and Plant Derived Drugs Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Botanical and Plant Derived Drugs Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Botanical and Plant Derived Drugs Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Botanical and Plant Derived Drugs Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Botanical and Plant Derived Drugs Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Abott Laboratories
  2. 8.1.1 Abott Laboratories Company Information
  3. 8.1.2 Abott Laboratories Business Overview
  4. 8.1.3 Abott Laboratories Botanical and Plant Derived Drugs Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Abott Laboratories Botanical and Plant Derived Drugs Product Portfolio
  6. 8.1.5 Abott Laboratories Recent Developments
  7. 8.2 Bayer Healthcare
  8. 8.2.1 Bayer Healthcare Company Information
  9. 8.2.2 Bayer Healthcare Business Overview
  10. 8.2.3 Bayer Healthcare Botanical and Plant Derived Drugs Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Bayer Healthcare Botanical and Plant Derived Drugs Product Portfolio
  12. 8.2.5 Bayer Healthcare Recent Developments
  13. 8.3 Bristol Myers
  14. 8.3.1 Bristol Myers Company Information
  15. 8.3.2 Bristol Myers Business Overview
  16. 8.3.3 Bristol Myers Botanical and Plant Derived Drugs Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Bristol Myers Botanical and Plant Derived Drugs Product Portfolio
  18. 8.3.5 Bristol Myers Recent Developments
  19. 8.4 Curapharm
  20. 8.4.1 Curapharm Company Information
  21. 8.4.2 Curapharm Business Overview
  22. 8.4.3 Curapharm Botanical and Plant Derived Drugs Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Curapharm Botanical and Plant Derived Drugs Product Portfolio
  24. 8.4.5 Curapharm Recent Developments
  25. 8.5 Bionova
  26. 8.5.1 Bionova Company Information
  27. 8.5.2 Bionova Business Overview
  28. 8.5.3 Bionova Botanical and Plant Derived Drugs Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Bionova Botanical and Plant Derived Drugs Product Portfolio
  30. 8.5.5 Bionova Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst